PORTLAND, Ore., July 19, 2021 /PRNewswire/ -- Aronora Inc., a clinical stage biotechnology company developing paradigm shifting therapies for serious hematologic diseases, today announced positive topline data from the Company's randomized placebo-controlled phase 2 clinical trial testing...
from PR Newswire: https://ift.tt/3eu5JuT
No comments:
Post a Comment